Candidalysin drives epithelial signaling, neutrophil recruitment, andimmunopathology at the vaginal mucosa by Richardson, Jonathan P. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1128/IAI.00645-17
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Richardson, J. P., Willems, H. M. E., Moyes, D. L., Shoaie, S., Barker, K. S., Tan, S. L., ... Peters, B. M. (2018).
Candidalysin drives epithelial signaling, neutrophil recruitment, andimmunopathology at the vaginal mucosa.
Infection and Immunity, 86. https://doi.org/10.1128/IAI.00645-17
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 10. Jul. 2020
 1 
Title: Candidalysin drives epithelial signaling, neutrophil recruitment, and 1 
immunopathology at the vaginal mucosa. 2 
 3 
Running title: Candidalysin and vaginitis 4 
 5 
By: Jonathan P. Richardson1#, Hubertine M.E. Willems2#, David L. Moyes1,3, Saeed 6 
Shoaie3, Katherine S. Barker2, Shir Lynn Tan1, Glen E. Palmer2, Bernhard Hube4,5, 7 
Julian R. Naglik1*, Brian M. Peters2* 8 
 9 
Affiliations: 1King’s College London, Division of Mucosal and Salivary Biology, London, 10 
UK; 2University of Tennessee Health Science Center, Department of Clinical Pharmacy, 11 
Memphis, TN, USA; 3King’s College London, Centre for Host-Microbiome Interactions, 12 
London, UK; 4Department of Microbial Pathogenicity Mechanisms, Hans Knöll Institute, 13 
Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany; 14 
5Friedrich-Schiller-University Jena, Germany. 15 
#denotes primary authors of equal contribution 16 
*denotes corresponding authors of equal contribution 17 
 18 
Corresponding authors: 19 
 20 
Brian M Peters, PhD    Julian R Naglik, PhD 21 
Dept. of Clinical Pharmacy and   Division of Salivary and Mucosal Biology 22 
Translational Science    Dental Institute  23 
College of Pharmacy    King’s College London  24 
Univ. of Tennessee Health Science Center London, SE1 UL, UK  25 
881 Madison Ave, Memphis, TN  38163  phone: +44 (0)20 7848 6123 26 
phone: 901-448-2724    email: julian.naglik@kcl.ac.uk  27 
email: brian.peters@uthsc.edu    28 
 29 
 2 
 30 
ABSTRACT 31 
  32 
Unlike other forms of candidiasis, vulvovaginal candidiasis, caused primarily by 33 
the fungal pathogen Candida albicans, is a disease of immunocompetent and otherwise 34 
healthy women. Despite its prevalence, the fungal factors responsible for initiating 35 
symptomatic infection remain poorly understood. One of the hallmarks of vaginal 36 
candidiasis is the robust recruitment of neutrophils to the site of infection, which 37 
seemingly do not clear the fungus, but rather exacerbate disease symptomatology. 38 
Candidalysin, a newly discovered peptide toxin secreted by C. albicans hyphae during 39 
invasion, drives epithelial damage, immune activation and phagocyte attraction. 40 
Therefore, we hypothesized that Candidalysin is crucial for vulvovaginal candidiasis 41 
immunopathology. 42 
Anti-Candida immune responses are clearly anatomical site specific, as effective 43 
gastrointestinal, oral, and vaginal immunity is uniquely compartmentalized. Thus, we 44 
aimed to identify the immunopathologic role of Candidalysin and downstream signaling 45 
events at the vaginal mucosa. Microarray analysis of C. albicans-infected human 46 
vaginal epithelium in vitro revealed signaling pathways involved in epithelial damage 47 
responses, barrier repair, and leukocyte activation. Moreover, treatment of A431 vaginal 48 
epithelial cells with Candidalysin induced dose-dependent pro-inflammatory cytokine 49 
responses (including IL-1α, IL-1β and IL-8), damage, and activation of c-Fos and 50 
mitogen activated protein kinase (MAPK) signaling, consistent with fungal challenge. 51 
Mice intravaginally challenged with C. albicans strains deficient in Candidalysin 52 
exhibited no differences in colonization or hyphal burdens as compared to isogenic 53 
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controls. However, significant decreases in neutrophil recruitment, damage, and pro-54 
inflammatory cytokine expression were observed with these strains. Our findings 55 
demonstrate that Candidalysin is a key hypha-associated virulence determinant 56 
governing the immunopathogenesis of C. albicans vaginitis. 57 
 58 
INTRODUCTION 59 
Vulvovaginal candidiasis (VVC), caused primarily by the polymorphic fungal 60 
pathogen Candida albicans, remains a serious worldwide health concern leading to 61 
significant quality of life issues for immunocompetent women (1). Symptomatic VVC is 62 
manifested by itching, burning, and pain sensation at the vaginal and vulvar tissue, 63 
often accompanied by odorless vaginal discharge (2). Globally, VVC is estimated to be 64 
the most prevalent human fungal infection, with over 75% of women experiencing at 65 
least one episode in their lifetime and 5-8% suffering from recurrent infection (3). In 66 
recent years, VVC has been described as an immunopathology, in which the host 67 
neutrophil response actually exacerbates disease symptoms, yet fails to adequately 68 
control the fungus (4, 5). While much effort has been placed on defining host 69 
immunological mechanisms contributing to VVC protection, the fungal virulence factors 70 
that dictate conversion from asymptomatic colonization to fulminant infection remain 71 
poorly understood. 72 
Using model systems, several laboratories have collectively begun to unravel this 73 
complex host-pathogen interaction. Studies revealed that vaginal epithelial cell damage 74 
and immune activation is dependent on C. albicans hypha formation, with epithelial 75 
immunity being mediated via the MAPK transcription factor c-Fos and regulated by the 76 
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MAPK phosphatase MKP1 (6). This MAPK/c-Fos/MKP1 pathway is able to discriminate 77 
between C. albicans yeast and hyphal cells and is retained between both vaginal and 78 
oral epithelia (7, 8). The activation of this signaling pathway is also coupled with lactate 79 
dehydrogenase (LDH) release, a marker of epithelial damage (6). Therefore, the ability 80 
of C. albicans to form hyphae and breach the epithelial barrier governs innate cytokine 81 
release and pro-inflammatory responses. 82 
Using a clinically relevant murine model of VVC, it was also determined that 83 
genetic blockade of hypha formation (e.g. efg1Δ/Δ, efg1Δ/Δ/cph1Δ/Δ, NRG1 84 
overexpression) failed to induce hallmark immunopathology at the vaginal mucosa, 85 
including polymorphonuclear leukocyte (PMN/neutrophil) recruitment, S100A8 release, 86 
IL-1β production, and LDH release confirming a crucial role for hyphae in this disease 87 
(9). Moreover, depletion of neutrophils in vivo failed to reduce LDH release from mice 88 
infected with hypha-competent strains of C. albicans (9, 10). Although, depletion of 89 
PMNs did significantly reduce several hallmark cytokines and chemokines during 90 
infection. These data suggest that C. albicans directly damages the vaginal mucosa 91 
which elicits migratory neutrophils as secondary effectors that amplify symptomatic 92 
vaginal inflammation. However, the fungal factors and mechanisms that contribute to 93 
neutrophil recruitment and induction of immunopathology remain elusive.  In general, 94 
these experiments recapitulated findings previously observed using human vaginal 95 
epithelial cell lines (6). Using a combination of RNA-Seq and targeted knockout studies, 96 
it was demonstrated that the NLRP3 inflammasome, a host signaling complex activated 97 
in response to cellular damage, is crucial for IL-1β release and PMN recruitment to the 98 
vaginal mucosa during C. albicans infection, consistent with candidal infection at other 99 
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anatomical sites (11). However, an important question remained: is hypha formation per 100 
se sufficient for damage-induced inflammation or are distinct fungal factors associated 101 
with the morphogenetic transition involved in these processes? 102 
Until recently, individual gene deletions in C. albicans have demonstrated only 103 
modest phenotypic alterations with respect to fungal colonization or cytokine signaling 104 
at the vaginal mucosa; the greatest reported effects being with deletion of the secreted 105 
aspartyl proteinase genes, SAP2 and SAP5 (11-14). However, recent work has 106 
revealed that the C. albicans ECE1 (extent of cell elongation) gene product is crucial for 107 
cellular damage, innate cytokine production, and neutrophil recruitment during murine 108 
oropharyngeal candidiasis (OPC). ECE1, a highly expressed, hypha-associated gene 109 
encodes a protein (Ece1p) that is processed into eight distinct peptides by the fungal 110 
protease Kex2p (15, 16). Genetic, biochemical and functional assays determined that 111 
amino acids 62-92 of Ece1p encode a fungal toxin termed Candidalysin, which 112 
possesses both lytic and immunostimulatory activity (including MAPK signaling) on oral 113 
epithelial cells (16). Importantly, an ece1Δ/Δ null mutant retains the capacity to form 114 
hyphae yet is unable to induce an inflammatory response. Moreover, ECE1 expression 115 
is largely dependent on the Efg1 transcription factor, likely explaining why efg1Δ/Δ and 116 
efg1Δ/Δ/cph1Δ/Δ mutants fail to fully activate MAPK signaling and immunopathology in 117 
oral or vaginal epithelium (6, 8, 9, 17). 118 
Given these similarities, we hypothesized that Candidalysin may comparably 119 
activate vaginal epithelial cells and govern VVC immunopathology in vivo. This study 120 
demonstrates that a single fungal factor, Candidalysin, is responsible for inducing 121 
vaginal cellular damage and pro-inflammatory responses during C. albicans infection in 122 
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vitro and in vivo. As such, the identification of a secreted toxin as the factor responsible 123 
for driving symptomatic vaginal inflammation may offer novel treatment modalities for 124 
arresting symptomatic disease. 125 
 126 
RESULTS 127 
Differential gene expression and pathway induction in reconstituted human 128 
vaginal epithelium following C. albicans challenge. The reconstituted human vaginal 129 
epithelium (RVE) model is an excellent in vitro surrogate to study epithelial-specific 130 
responses of vaginal candidiasis, as the tissue layer is sufficiently differentiated and 131 
supports robust hyphal invasion and infected RVE tissue largely resemble the in vivo 132 
situation (18, 19). In order to elucidate global host transcriptomic changes in vaginal 133 
epithelium in response to challenge with C. albicans as compared to PBS sham control, 134 
total epithelial RNA was selectively isolated from RVE at 6 and 24 h post-challenge and 135 
subjected to microarray analysis. As with oral epithelium, the intermediate (6 h) time 136 
point is associated with initial fungal adherence and detection, while the late (24 h) time 137 
point is associated with fungal invasion and cellular damage (8, 20). Approximately 800 138 
and nearly 4,000 genes were differentially expressed (P <0.001) at least 2-fold at 6 and 139 
24 h, respectively in response to C. albicans (Fig. 1). Comparatively, few genes were 140 
regulated in response to PBS-sham treatment at the same time points (Fig. S1). At the 141 
intermediate stage of infection (6 h post-infection), the majority of differentially 142 
expressed genes are up-regulated (Fig 1A) with none showing strong down-regulation. 143 
However, by late stages of infection (24 h), there is an increase in the proportion of 144 
genes showing down-regulated expression (Fig 1B). Over half of the genes showing up-145 
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regulation at 6 h were similarly up-regulated at 24 h (Fig 1C). Surprisingly, relatively few 146 
genes were strongly (>4 fold) down-regulated in response to fungal challenge at either 147 
time point. Commensurate with these associations, both time points include genes 148 
associated with MAPK (phosphatases, accessory proteins and transcription factors), 149 
NF-κB and PI3K signaling. The early time point includes the expression of many genes 150 
encoding early/immediate transcription factors (such as c-Fos) and signaling modulators 151 
(such as the DUSP phosphatases) that are associated with the immediate signaling 152 
response to the presence of C. albicans. However, the late time point contains a far 153 
more diverse set of genes, such as downstream effector genes, including cytokines. 154 
This pool represents the cumulative responses driven by the continued presence of C. 155 
albicans hyphae along with subsequent released host factors. At both time points, the 156 
up-regulated expression of a variety of transcription factor genes associated with other 157 
signaling pathways was observed, as well as genes coding for cytokines and effector 158 
molecules.   159 
 Gene ontology, pathway, and network mapping using the web-based analysis 160 
package DAVID revealed profiles from C. albicans infected cells as consistent with 161 
MAPK, NF-κB PI3K, ErbB receptor, and TNF signaling pathways (Fig. 2). Pathways 162 
involving extracellular matrix remodeling, including proteoglycans in cancer, focal 163 
adhesion, adherens junctions, and tight junctions were also significantly enriched during 164 
C. albicans infection. Pathways involved in responses to infection by other microbes, 165 
including Epstein-Barr virus, Shigella, Hepatitis B, Influenza A, Herpes virus, 166 
Salmonella, and trypanasome infection were also predicted to be activated, suggesting 167 
conservation of epithelial responses against a broad array of pathogens. Pathways 168 
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predicted to be activated were generally conserved at 6 h and 24 h time points. A list of 169 
individually expressed genes may be found in Table S1.  170 
 Genes involved in innate inflammatory signaling were strongly induced by 171 
C. albicans, including those encoding cytokines IL-8 (100-fold), IL-1A (18-fold), IL-1B 172 
(3.8-fold), CXCL1 (19-fold), CXCL2 (26-fold), GM-CSF (10-fold), and prostaglandin 173 
synthase PTGS2 (7.3-fold), many of which play critical roles in recruiting inflammatory 174 
cells (particularly neutrophils) to the site of infection. Similar to previous findings, there 175 
was clear induction of genes associated with MAPK activity: MAP3K2 (6.8-fold), 176 
MAP2K3 (4-fold), MAP3K9 (4-fold), MAP4K4 (2.7-fold). Additionally, C. albicans 177 
infection led to epithelial induction of c-FOS (32-fold) and c-JUN (17.7-fold), which 178 
encode members of two families that form the heterodimeric transcription factor AP1, a 179 
major effector of MAPK activation. The dual specificity phosphatase 1 (DUSP1) gene, 180 
encoding a regulator of MAPK signaling, was also elevated (6.7-fold) in response to C. 181 
albicans. 182 
 A number of other genes were induced that are involved in tissue repair, wound 183 
healing, or dampening of active inflammation, including the genes coding for IL-24 (2.3-184 
fold) and IL-1RN (4-fold) were increased during C. albicans infection (21, 22). 185 
Interestingly, a number of other related genes were also induced, including genes 186 
coding for HBEGF (heparin binding EGF-like growth factor, 39.5-fold) and EREG 187 
(epiregulin, 6-fold) that are members of the epidermal growth factors (EGFs). They exert 188 
their function by binding to their cognate receptors EGFR or v-erb-b2 oncogene 189 
homolog (ERBB) to induce cellular proliferation and healing of skin and epidermal 190 
tissues (23, 24). 191 
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 192 
Candidalysin damages and activates vaginal epithelial cells. As we observed an 193 
up-regulated expression of genes encoding several pro-inflammatory cytokines (e.g. IL-194 
1A, IL-1B, IL-8, GM-CSF) and chemokines during RVE challenge with C. albicans at 195 
time points when hyphae invaded the vaginal tissue, we sought to determine whether 196 
the hyphae associated peptide toxin Candidalysin similarly elicited these effector and 197 
damage responses. Indeed, there was a dose-dependent release of lactate 198 
dehydrogenase (LDH) when Candidalysin was applied to A431 cells (Fig. 3A). 199 
Significant levels of cellular damage were observed with doses above 15 μM as 200 
compared to treatment with the vehicle control. 201 
Vaginal epithelial cells respond to C. albicans hyphae by activating the p38-202 
MAPK and ERK1/2-MAPK signalling pathways, resulting in the regulated secretion of 203 
proinflammatory cytokines (6). However, the fungal factors governing epithelial 204 
activation are unknown. To assess whether Candidalysin is capable of activating p38-205 
MAPK and ERK1/2-MAPK signalling pathways, epithelial cells were exposed to 206 
Candidalysin in vitro, and c-Fos production/MKP1 phosphorylation was assessed by 207 
Western blotting (Fig. 3B). The c-Fos/p-MKP1 response was induced strongly by 70 and 208 
15 μM Candidalysin, whereas the vehicle was unable to activate signalling. Concomitant 209 
with damage, treatment with Candidalysin caused a dose-dependent increase in the 210 
release of IL-1α, IL-1β, G-CSF, GM-CSF and IL-8 in spent culture supernatants (Fig. 211 
3C-H). The lone exception was IL-6, which was only significantly elevated at the highest 212 
Candidalysin concentration (70 μM). With the exception of IL-6, all cytokines assayed 213 
were significantly induced at Candidalysin doses above 3 μM; however, this dose was 214 
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insufficient to cause significant damage (Fig. 3A), suggesting that Candidalysin exhibits 215 
dual functionality, serving both immunostimulatory and lytic roles against vaginal 216 
epithelial cells, similar to that observed in oral epithelia (16). 217 
 218 
Candidalysin is required for vaginitis immunopathology. We next questioned 219 
whether Ece1 and/or Candidalysin contribute to immunopathology in an established 220 
estrogen-dependent mouse model of vulvovaginal candidiasis (VVC). Therefore, we 221 
utilized strains of C. albicans that had been deleted for both copies of ECE1 (ece1Δ/Δ) 222 
and restored with one full-length allele (ece1Δ/Δ+ECE1) or one mutant allele lacking the 223 
Candidalysin-encoding region of ECE1 (ece1Δ/Δ+ECE1Δ184-279), along with the 224 
appropriate parental isogenic control (BWP17+CIp30: from here referred to as “WT”). 225 
Somewhat surprisingly, recovered fungal burdens from the vaginal lavage fluid were not 226 
significantly different between strains at either d 3 (Fig. 4A) or d 7 (Fig. 4B) post-227 
inoculation. However, there was a significant reduction in the number of neutrophils 228 
recruited into the vaginal lumen during challenge with either ece1Δ/Δ or 229 
ece1Δ/Δ+ECE1Δ184-279 strains, which was restored to WT levels during infection with the 230 
ece1Δ/Δ+ECE1 re-integrant strain (Fig. 4C,D,G, yellow arrows). Consistent with this 231 
phenotype, levels of the damage biomarker LDH were significantly reduced with these 232 
same mutants as compared to infection with WT or ece1Δ/Δ+ECE1 re-integrant (Fig. 233 
4E,F). Given our previous data using hypha deficient strains, a morphogenesis defect 234 
may account for this phenotype (9). However, ece1Δ/Δ and ece1Δ/Δ+ECE1Δ184-279 235 
strains formed hyphae normally at the vaginal mucosa, as did WT and ece1Δ/Δ+ECE1 236 
strains (Fig. 4G, green arrows). Thus, these results demonstrate that Ece1 is required 237 
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for vaginal immunopathogenesis in vivo and that hypha formation alone is insufficient to 238 
elicit hallmark immunopathology. 239 
 240 
Candidalysin-dependent innate cytokine expression is conserved between mouse 241 
and human. We also wanted to determine whether the Candidalysin-induced innate 242 
immune response observed in human vaginal epithelial cells paralleled cytokine 243 
expression in the murine vaginal mucosa in vivo. RNA was isolated from whole vaginas 244 
of mice challenged with WT, ece1Δ/Δ, ece1Δ/Δ+ECE1, ece1Δ/Δ+ECE1Δ184-279 and PBS 245 
sham and gene expression assessed by qPCR. Overall, cytokine gene expression 246 
patterns were similar between in vitro and in vivo samples, including Candidalysin-247 
induced expression of the genes Il-6, Cxcl2, Il-1a, and Il-1b (Fig. 5A,C-E). There was a 248 
similar trend for expression of the genes Cxcl1 and Gm-csf, although only the ECE1 null 249 
mutant (ece1Δ/Δ) demonstrated a statistically significant reduction in cytokine gene 250 
induction (Fig. 5B,F). Unexpectedly, G-csf gene expression was not increased during 251 
challenge with any of the fungal strains, unlike that observed with Candidalysin 252 
treatment (Fig. 5G). In the oral cavity, C. albicans induces expression of the 253 
antimicrobial peptide (AMP) cathelicidin, of which the murine equivalent is the 254 
cathelicidin related AMP (CAMP) (25). Interestingly, the gene encoding for CAMP was 255 
not induced in the vagina by Candidalysin, and in fact was down-regulated similarly by 256 
all strains as compared to sham treatment (Fig. 5H). However, induction of the 257 
antimicrobial peptide β-defensin 3 (mBD3) gene was Candidalysin-dependent (Fig. 5I). 258 
 We also sought to determine if two inflammatory markers previously identified as 259 
associated with VVC immunopathology were regulated in a Candidalysin-dependent 260 
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manner. Expression of the gene coding for S100a8, a calcium-binding protein with 261 
important functions in antifungal defense and danger responses and strongly induced 262 
during C. albicans infection, was almost completely absent during infection with 263 
Candidalysin deletion strains (Fig. 5J) (26, 27). Similarly, the gene encoding serum 264 
amyloid A3 (Saa3), an inducible acute phase apolipoprotein capable of recruiting 265 
immune cells to inflammatory sites, was similarly increased in a Candidalysin-266 
dependent fashion (Fig. 5K) (28, 29). 267 
 Lastly, we validated whether induction of several of these cytokines at the protein 268 
level by ELISA at both d 3 and d 7 p.i. was Candidalysin-dependent.  Indeed, 269 
C. albicans-mediated secretion of IL-1α, IL-1β, CXCL2, and S100A8 into the vaginal 270 
lavage fluid required expression of a functional Candidalysin (Fig. 6A-H). Despite 271 
increased expression of the genes encoding for IL-6, CXCL1, and GM-CSF in vaginal 272 
tissue, we were unable to demonstrably quantify these cytokines at the protein level in 273 
the lavage fluid of mice inoculated with any of the C. albicans strains tested (data not 274 
shown).  275 
 276 
DISCUSSION 277 
In recent years, vulvovaginal candidiasis has been identified as an 278 
immunopathology, in which the host immune response, orchestrated by a series of pro-279 
inflammatory cytokines and chemokines, actually exacerbates symptomatic disease. A 280 
landmark live-challenge study conducted by Fidel and colleagues led to this paradigm 281 
shifting hypothesis, as presence of neutrophils in the vaginal lavage fluid of women 282 
intravaginally inoculated with C. albicans was tightly correlated to disease 283 
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symptomatology (e.g. vaginal itching, burning, discomfort) (4). Ultimately, initial 284 
activation of innate immune signaling recruit neutrophils to the vaginal mucosa and 285 
experimental evidence suggests that these cells then amplify the inflammatory cascade, 286 
seemingly without reducing fungal burden (27, 30). Although several data suggest that 287 
C. albicans hyphal morphology is associated with immunopathology, the precise 288 
virulence attributes that enable C. albicans to initiate these early signaling events at the 289 
vaginal mucosa have not been well defined. The in vitro and in vivo data presented in 290 
this study identify Candidalysin as the crucial virulence factor that drives both, 291 
C. albicans-induced neutrophil recruitment and vaginal immunopathogenesis. 292 
The vaginal epithelial response to C. albicans infection provides new insight into 293 
immunopathological signaling. Microarray data derived from C. albicans-infected 294 
human vaginal epithelial cells strongly paralleled what had been observed previously 295 
using targeted multiplex cytokine assays to determine host response to vaginal infection 296 
(6). Unsurprisingly, many of the genes uncovered by RNA-Seq as differentially 297 
regulated during murine vaginitis were not found in the human microarray datasets (11). 298 
The first explanation of this is that the human response (microarray data) is not strictly 299 
homologous with the murine response. However, given the similarity and linkage of 300 
immunopathology with neutrophil influx to the vaginal lumen in both human and murine 301 
vaginal infections, this explanation seems less likely. A more plausible explanation is 302 
that the microarray data presented here provide an epithelial-specific response that is 303 
independent of hormonal modulation or other cell-type intervention. Murine RNA-Seq 304 
data were derived from whole vaginal tissue, thus hematopoetic and stromal 305 
compartments were similarly represented (11). While each strategy offers its own 306 
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unique strengths and weaknesses, direct comparison between datasets must be done 307 
with caution. However, despite these methodological differences, there was relatively 308 
strong conservation between pro-inflammatory responses in both datasets. In both 309 
human and murine tissues, expression of phospholipase A2 (PLA2GB4) and 310 
prostaglandin synthase 2 (PTGS2) genes were both increased, suggesting activation of 311 
eicosanoid signaling at the vaginal mucosa. Indeed, this had been previously (indirectly) 312 
confirmed in vivo by measuring prostaglandin E2 metabolites in the vaginal lavage fluid 313 
of infected mice and human volunteers (11, 31). Increased expression of IL-1B and the 314 
IL-1 receptor antagonist (IL1-RN) genes was also identified in both datasets, suggesting 315 
that IL-1 circuit is activated in a C. albicans-specific manner at the vaginal epithelium. 316 
Similarly, previous work conducted by Fidel and colleagues investigating the release of 317 
S100A8/A9 alarmins in murine vaginal lavage fluid following C. albicans infection and 318 
immunohistological staining identified their increased expression in the vaginal 319 
epithelium (30). Expression of S100A8/9 genes was not identified in the microarray 320 
analysis per se, but a gene encoding the functionally related RAGE-agonist S100P, also 321 
implicated in innate inflammation and AP1 activation, was induced following C. albicans 322 
challenge (32). In a similar fashion, a gene encoding the neutrophil attractant CXCL2, a 323 
downstream effector of Th17 responses, was strongly up-regulated in all datasets, 324 
suggesting that this chemokine may play a major role in attracting neutrophils to the site 325 
of infection (33). 326 
An interesting observation from the microarray analysis was that a gene 327 
encoding the neuronal precursor of cell expressed developmentally down-regulated 9 328 
(NEDD9) was increased 5.3-fold post-C. albicans challenge. Recently using RNA-Seq, 329 
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Liu et al. demonstrated that the NEDD9 pathway was activated in oral keratinocytes 330 
following C. albicans infection (34). However, further analysis by this group, examining 331 
gene expression derived from longitudinal vaginal swabs during healthy and 332 
symptomatic vaginitis states revealed that NEDD9 was not activated at the vaginal 333 
mucosa, but instead activated pathways were predicted to involve v-erb-b2 334 
erythroblastic leukemia viral oncogene homolog 2, (ERBB2) and platelet-derived growth 335 
factor (PDGF-BB) signaling in the vagina. Given these disparate results, it is unclear if 336 
NEDD9 may play a role in activating gene expression at the vaginal mucosa in 337 
response to C. albicans. Interestingly, our microarray dataset (human vaginal 338 
epithelium) did not directly demonstrate increased expression of genes encoding 339 
ERBB2 or PDGF-BB, but several genes coding for downstream targets of these factors 340 
were highly induced, including JUNB, FOS, DUSP5, NR4A1, IL-8, IL-1B, TNFAIP3, and 341 
EGR1, among others.  Many of these same downstream targets were previously found 342 
to be induced in oral epithelial cells on the protein level (35). Therefore, in vitro infection 343 
of A431 cells largely mimics responses observed in both oral epithelial cells and during 344 
clinical vaginitis. 345 
Another striking observation was the strong transcriptional up-regulation of the 346 
gene encoding EGF ligand heparin-binding EGF-like growth factor (HB-EGF, ~40-fold) 347 
and the gene coding for the enzyme heparin sulfate 3-O-sulfotransferase 1 (HS3ST1), 348 
suggesting the potential presence of heparin sulfate at the vaginal mucosa. Indeed, 349 
recent work by Yano et al. demonstrated that heparin sulfate can be recovered from the 350 
vaginal lavage fluid of mice and that its presence is enhanced by exogenous estrogen 351 
administration (36). Interestingly, treatment of recovered vaginal fluid with heparinase 352 
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restored the capacity of PMNs to kill C. albicans in vitro, suggesting that heparin sulfate 353 
may phenotypically alter or physically inhibit neutrophil-fungus interaction. One potential 354 
mechanism was presented whereby heparin sulfate outcompetes the fungal surface 355 
antigen Pra1 for its natural ligand Mac1 present on the surface of neutrophils to prevent 356 
killing of the fungus (36, 37). Although the precise role of heparin sulfate at the vaginal 357 
mucosa remains unclear, it is often up-regulated in other epithelial or epidermal tissues 358 
in response to damage, functioning in the tissue repair process (38). Therefore, the 359 
capacity of C. albicans hyphae and Candidalysin to damage epithelia and potentially 360 
elevate free vaginal heparin sulfate may indirectly contribute to a fungal fitness strategy 361 
to defend against PMN-mediated clearance at the mucosal surface. Collectively, these 362 
results may help explain why neutrophils are ineffective at reducing fungal burden 363 
during vaginitis, despite being robustly recruited to the vaginal lumen. 364 
Candidalysin: the key fungal factor driving damage and vulvovaginal 365 
immunopathogenesis. Previous data generated from our laboratories have 366 
demonstrated that both oral and vaginal epithelial cells can differentially sense and 367 
respond to yeast and hyphal forms of C. albicans (6, 8, 9). However, modestly different 368 
signaling mechanisms, cytokine secretion, and hyphal burden thresholds differentiate 369 
responses in oral and vaginal epithelial cells. For example, previous studies by Moyes 370 
et al. determined that the A431 vaginal cell line responds to C. albicans challenge in a 371 
similar fashion to TR146 oral cells, albeit at fungal burdens roughly one log greater (6). 372 
Moreover, the cytokines CCL20, G-CSF, and IL-6 were robustly secreted by oral 373 
epithelia in response to C. albicans infection. However, these responses were 374 
comparatively reduced or not observed during in vitro infection of vaginal epithelium or 375 
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at the murine vaginal mucosa. These differences in responses could be due to the 376 
abovementioned apparent elevated signaling threshold in vaginal cells or may represent 377 
site specific fine-tuning of mucosal immunity—a hypothesis supported by the observed 378 
differences in transcription factors activated in the two cell types (6, 8). Furthermore, 379 
some cytokines (e.g. IL-6) were induced by treatment with Candidalysin alone but not 380 
during infection with C. albicans. It is likely that Candidalysin concentration plays a 381 
major factor in its lytic and immunostimulatory function and currently it is unclear what 382 
general or microniche concentrations of Candidalysin are present in an ex vivo or in vivo 383 
setting or what other host or fungal factors it interacts with during infection.  384 
The hypothesis that epithelial surfaces can discriminate between yeast and 385 
hyphal forms of C. albicans has been established by linking hypha formation with the 386 
capacity to damage epithelial surfaces (6, 8). These observations have recently been 387 
extended into in vivo findings, as a similar phenomenon also appears to be true at the 388 
murine vaginal mucosa (9, 39). Indeed, hypha-deficient mutants of C. albicans fail to 389 
induce pro-inflammatory signaling, despite very high levels of colonization. One key 390 
feature explaining these dichotomous responses is lack of elicited epithelial damage 391 
and subsequent danger-associated molecular pattern (DAMP) release by hypha-392 
deficient strains. This hypothesis is further supported by studies examining the role of 393 
the NLRP3 inflammasome, a danger-sensing molecular complex, in mediating 394 
inflammation at both oral and vaginal mucosal surfaces (40, 41). The use of NLRP3-/- 395 
mice during oral and vaginal candidiasis has demonstrated that neutrophil migration and 396 
pro-inflammatory signaling is reduced in these animals, presumably due to a defect in 397 
the ability to recognize and respond to DAMP signals (11, 25, 42, 43). As for vaginal 398 
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candidiasis, a population-level genetic study revealed that the 12/9 genotype was 399 
significantly associated with high levels of NLRP3 effector cytokines found in the vaginal 400 
lavage fluid of women with recurrent VVC (RVVC), suggesting the recognition of DAMP 401 
signals likely prime the epithelial pro-inflammatory response (44). This concept of linking 402 
fungal pathogenicity to damage was further supported by findings from Schönherr et al. 403 
in which the virulence of clinical isolates of C. albicans was directly correlated with their 404 
capacity to induce oral mucosal insult (43). Notably, only the expression of 405 
ECE1/Candidalysin was strongly correlated with damage and pathogenesis in several 406 
(but not all) C. albicans isolates. However, it is likely that simultaneous and combined 407 
expression of several attributes (e.g. hyphae and Candidalysin) is required for full 408 
virulence. 409 
Given that the presence of Candidalysin is sufficient to induce damage to the 410 
vaginal mucosa and elicits inflammasome effector responses (i.e. IL-1β), it is possible 411 
that Candidalysin serves as a fungal DAMP capable of inflammasome activation. 412 
Typically, inflammasome activation requires two independent steps, the first of which is 413 
ligation of pattern recognition receptors that prime the response and a second damage 414 
step that activates the response (40). Obviously the lytic property of Candidalysin 415 
satisfies the second step but activation of the first step would likely depend on other 416 
cellular factors of C. albicans (e.g. cell surface components). However, results from 417 
Moyes et al, in which Candidalysin was mutated to contain a C-terminal alanine–alanine 418 
motif (Ece1-III62–93AA) retained immunostimulatory function in the absence of lytic 419 
activity, suggesting that structural recognition of this peptide may be sufficient to also 420 
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prime inflammasome activity or other inflammasome-independent inflammatory 421 
responses (16). Investigations are currently underway to address these possibilities. 422 
In summary, this study demonstrates that Candidalysin secretion is critical for the 423 
induction of immunopathological signaling at the vaginal mucosa, and that these 424 
responses are largely conserved at both human and murine epithelial surfaces. 425 
Furthermore, our findings decouple hypha formation from disease symptomatology and 426 
clearly link vaginitis immunopathogenesis with Candidalysin production and its capacity 427 
to directly damage the vaginal mucosa. In light of these findings, studies designed to 428 
determine the mechanistic interaction of Candidalysin with the vaginal epithelium are 429 
warranted. Therapeutic strategies to either neutralize Candidalysin itself, inhibit its 430 
expression, or block downstream host signaling pathways may offer a unique 431 
opportunity to more quickly arrest symptomatology of this most prevalent human fungal 432 
infection. 433 
 434 
MATERIALS AND METHODS 435 
Ethics statement. The animals used in this study were housed in AAALAC-approved 436 
facilities located at the University of Tennessee Health Sciences Center (UTHSC) in the 437 
Regional Biocontainment Laboratory (RBL). The UTHSC Animal Care and Use 438 
Committee approved all animals and protocols. Mice were given standard rodent chow 439 
and water ad libitum. Mice were routinely monitored for signs of distress, including 440 
noticeable weight loss and lethargy. 441 
 442 
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Cell lines, strains and primers. The A431 human vulvar epidermoid carcinoma cell 443 
line was used in this study. All C. albicans strains used, including Candidalysin deletion 444 
mutants, are those described by Moyes, et al (16, 45). All primers used for quantitative 445 
PCR (qPCR) are listed in Table S2.  446 
 447 
Microorganism growth. C. albicans strains were maintained as glycerol stocks stored 448 
at -80°C. A small amount of stock was spread onto yeast peptone dextrose (YPD) agar 449 
and incubated at 30°C for 48 h to obtain isolated colonies. A single colony was 450 
transferred to 10 mL of YPD liquid medium and incubated at 30°C with shaking at 200 451 
rpm for 16 h prior to vaginal infection. 452 
 453 
Microarray analysis. Reconstituted human vaginal epithelia (RVE: 5-day) created 454 
using the A431 cell line were purchased from SkinEthic Laboratories (France) and used 455 
as previously described (6). RNA was isolated from RVE infected with C. albicans 456 
SC5314 for 6 and 24 h or an equal volume of PBS using the GenElute total mammalian 457 
RNA miniprep kit (Sigma, UK) and trace genomic DNA removed using the Turbo 458 
DNase-free kit (Ambion, UK). For microarray analysis, RNA was amplified using the 459 
MessageAmp Premier RNA Amplification Kit (Ambion, UK) and hybridized onto U133a 460 
2.0 gene chips (Affymetrix, UK) after fragmentation by metal-induced hydrolysis into 35-461 
200 nucleotide fragments according to standard protocols. Chips were scanned 462 
(Affymetrix GeneChip Scanner 3000) and assessed using Affymetrix Command 463 
Console (AGCC) software suite. This data was statistically analyzed using the 464 
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Bioconductor R package, PIANO. Gene Ontology and pathway analysis was performed 465 
using both PIANO and DAVID (46, 47). 466 
 467 
Cytokine release. A431 vaginal epithelial cells were cultured in Dulbecco’s Modified 468 
Eagle Medium Nutrient Mixture + L-glutamine (Life technologies) supplemented with 469 
10% (v/v) heat-inactivated fetal bovine serum (Life technologies) and 1% (v/v) penicillin-470 
streptomycin (Sigma) at 37°C, 5% CO2. Candidalysin peptide 471 
(SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK) was purchased from Peptide Protein 472 
Research Ltd (UK). Prior to Candidalysin challenge, confluent A431 epithelial cells were 473 
serum-starved overnight and all experiments were carried out in serum-free DMEM 474 
medium. Cells were incubated with Candidalysin (prepared as a 10 mg/mL stock in 475 
sterile water)) at doses of 1.5, 3, 15 and 70 μM for 2 h at 37°C in 5% CO2. Sterile water 476 
(vehicle only) controls were also included. Culture supernatants were then isolated and 477 
human IL-1α, IL-1β, IL-6, IL-8, GM-CSF, and G-CSF quantified by Magnetic Luminex 478 
Performance Assay (Biotechne) and Bio-Plex 200 System (BioRad) according to the 479 
manufacturer’s instructions. 480 
 481 
Epithelial cell damage assay. Damage to epithelial monolayers following a 24 h 482 
challenge with Candidalysin was determined by quantification of lactate 483 
dehydrogenease activity in cell culture supernatants using a CytoTox 96 non-radioactive 484 
cytotoxicity assay (Promega) according to the manufacturer’s instructions as previously 485 
described (16). Porcine lactate dehydrogenase (Sigma) was used to create the 486 
standard curve. 487 
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 488 
Preparation of protein extracts. Epithelial cells were lysed using a modified RIPA 489 
buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% 490 
sodium deoxycholate, 0.1% SDS) containing protease (Sigma-Aldrich) and 491 
phosphatase (Perbio Science) inhibitors. Crude lysates were cleared by centrifugation 492 
at 4°C and protein concentration estimated by BCA assay (Thermo Scientific) according 493 
to the manufacturer’s instructions. 494 
 495 
SDS PAGE and Western blotting. Proteins were resolved by electrophoresis on 12% 496 
SDS PAGE gels using a mini-protean tetra cell system (BioRad). Electrophoresed 497 
proteins were transferred to nitrocellulose membrane (BioRad) using a mini-transblot 498 
electrophoretic transfer cell (BioRad). p-DUSP1/MKP1 (S359) and c-Fos rabbit 499 
monoclonal antibodies were purchased from Cell Signaling Technologies. Actin (clone 500 
C4) mouse monoclonal antibody was purchased from Millipore. Peroxidase-conjugated 501 
Affinipure Goat anti-mouse and anti-rabbit IgG secondary antibodies were purchased 502 
from Jackson Immune Research. Membranes were blocked in 1 × TBS (Severn 503 
Biotech) containing 0.001% (v/v) tween-20 (Acros Organics) and 5% (w/v) fat free milk 504 
powder (Sainsbury’s). Primary antibodies diluted (1:1000 or 1:10,000 as suggested by 505 
manufacturer) in TBS-tween and 5% milk (c-Fos), or TBS-tween and 5% bovine serum 506 
albumin (p-DUSP1/MKP1) were added and membranes incubated overnight at 4°C with 507 
gentle shaking. Following incubation, membranes were washed with 1 × TBS containing 508 
0.01% (v/v) tween-20, diluted (1:10,000) HRP-conjugated secondary antibody added 509 
and membranes incubated for 1 h at room temperature. Membranes were washed as 510 
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described and exposed to Immobilon Western Chemiluminescent HRP substrate 511 
(Millipore) prior to visualisation by exposure to film (GE Healthcare). Alpha-actin was 512 
used as a loading control. 513 
 514 
Murine model of vaginal candidiasis. A murine model of Candida vaginitis was 515 
utilized as described previously (9, 11, 48). Female 6-8 week old C57BL/6 mice were 516 
purchased from Charles River laboratories and housed in isolator cages mounted onto 517 
ventilated racks. Mice were administered 0.1 mg of estrogen (β-estradiol 17-valerate; 518 
Sigma) dissolved in 0.1 mL sesame oil subcutaneously 72 h prior to inoculation with C. 519 
albicans. Stationary-phase cultures of C. albicans strains were washed three times in 520 
sterile, endotoxin-free phosphate-buffered saline (PBS) and resuspended in a 0.2 × 521 
volume of PBS. Cell suspensions were diluted, counted on a Neubauer hemocytometer, 522 
and adjusted to 5 × 108 CFU/mL in sterile PBS. Estrogen-treated mice were 523 
intravaginally inoculated with 10 μL of the standardized blastoconidial cell suspension, 524 
generating an inoculum size of 5 × 106 blastoconidia. At d 3 and/or d 7 p.i. mice 525 
underwent vaginal lavage with 100 μL of PBS. Resultant lavage fluids were spiked with 526 
1 μL of 100 × EDTA-free protease inhibitors (Roche) and kept on ice until processing for 527 
immunopathological markers. After sacrifice, vaginal tissue was surgically excised and 528 
stored for downstream analyses. All animal experiments were conducted with n=4 mice 529 
per group, repeated, and data combined unless noted otherwise. 530 
 531 
Assessment of fungal burden and vaginitis immunopathology. All 532 
immunopathological markers were assessed as described previously (9). (i) Lavage 533 
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fluid was serially diluted 10-fold using the drop-plate method, plated onto YPD agar 534 
containing 50 μg/mL chloramphenicol, plates incubated for 24 h at 37°C, and the 535 
resulting colonies enumerated. CFU/mL values per group are reported as medians. (ii) 536 
Lavage fluid (10 μL) was smeared onto glass slides and stained by the Papanicolaou 537 
technique to assess polymorphonuclear leukocyte (PMNs) recruitment (small, blue, 538 
cells with multi-lobed nuclei). PMNs were counted in 5 non-adjacent fields by standard 539 
light microscopy using a 40X objective and values reported as mean + standard error of 540 
the mean (SEM).  (iii) Murine IL-1α, IL-1β, CXCL2, and S100A8 was assessed in 541 
clarified, diluted (1:20-1:100) vaginal lavage fluid using commercial enzyme-linked 542 
immunosorbent assays (eBioscience, R&D Systems) according to manufacturer’s 543 
protocol. Results are reported as the mean + SEM. (iv) Lactate dehydrogenase (LDH) 544 
activity was measured in clarified, diluted (1:100) lavage fluid using the commercial 545 
available CytoTox 96 nonradioactive cytotoxicity assay (Promega). Results are reported 546 
as the mean + SEM.  547 
 548 
Isolation of RNA from vaginal tissue. RNA was extracted from whole vaginas as 549 
described previously (11). At d 3 p.i., vaginal tissue was surgically excised, immediately 550 
placed into RNALater (Thermo Fisher), and incubated at 4°C overnight. The following 551 
day, tissues were transferred to TRI Reagent (Sigma), finely minced with scissors, 552 
mechanically homogenized (Pro Scientific), and centrifuged at 12,000 × g for 10 min at 553 
4°C. RNA was isolated by chloroform-ethanol precipitation and the pellet resuspended 554 
in nuclease-free water according to TRI Reagent instructions. RNA concentration was 555 
measured by spectroscopy at A260/280 and integrity verified by 3-(N-556 
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morpholino)propanesulfonic acid (MOPS) gel electrophoresis to visualize intact 18s and 557 
28s rRNA bands.  558 
 559 
qRT-PCR analysis. RNA from vaginal tissue was isolated as described above. RNA 560 
concentrations were equalized amongst samples and 200 ng aliquots were treated with 561 
RNase-free DNase according to the manufacturer’s instructions (Thermo Scientific). 562 
RNA was reverse transcribed using random hexamers and the RevertAid kit according 563 
to the manufacturer’s protocol (Thermo Scientific). Proprietary primer sets spanning 564 
exon-exon junctions were ordered from IDT for murine Il-6, Cxcl1, Cxcl2, Il-1a, Il-1b, 565 
Gm-csf, G-csf, Camp, S100a8, Saa3, Defb3, and Act1b (Table S2). All primers were 566 
used at the manufacturer’s recommended concentrations along with 2 × Maxima Sybr 567 
Green mix (Bio-rad) to amplify 20 ng of cDNA. qPCR reactions were monitored and 568 
analyzed with the Applied Biosystems 7500 platform and associated software. 569 
Expression levels of target genes in infected mice were compared to a reference gene 570 
(ACT1B) and naïve controls using the ∆∆Ct method as described previously (49). 571 
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 746 
FIGURE LEGENDS 747 
Figure 1. Global differential gene expression induced during C. albicans infection 748 
of Reconstituted Vaginal Epithelium (RVE). RVE were challenged with C. albicans or 749 
mock infected with PBS for 6 or 24 h and differential gene expression was assessed by 750 
microarray analysis. Volcano plots depicting log2 fold expression changes of genes 751 
between (A) 6 h and (B) 24 h time points following challenge with C. albicans or PBS 752 
sham. (C) After adjusting for p-value and false discovery rate (fdr, p< 0.01) gene, Venn-753 
diagram plot depicts absolute number of genes expressed between C. albicans at 6 h 754 
(red) and 24 h (green). 755 
 756 
Figure 2. Host signaling pathways predicted to be activated during C. albicans 757 
infection of RVE. Based on differential gene expression, KEGG pathway analysis 758 
using the DAVID web-based package revealed several host pathways predicted to be 759 
significantly (p<0.0001) activated at (A) 6 h or (B) 24 h. Pathways are listed in order of 760 
highest probability of activation. Significance was assessed using DAVID statistical 761 
package via ANOVA analysis. 762 
 763 
Figure 3. Candidalysin is sufficient to induce cellular damage and 764 
proinflammatory responses in vaginal epithelial cells. (A) A431 vaginal epithelial 765 
 35 
cells were exposed to Candidalysin (70, 15, 3 and 1.5 μM) for 24 h and cellular damage 766 
quantified by LDH assay. Data are presented as fold change relative to vehicle control. 767 
Statistics are applied relative to the vehicle control (n=3 biological repeats). (B) Western 768 
blot analysis of the vaginal epithelial response to different concentrations of 769 
Candidalysin. Epithelial cell lysates (20 μg total protein) were probed with anti c-Fos and 770 
anti p-MKP1 antibodies. One representative blot presented (from n=3 biological 771 
repeats). (C-H) Quantification of cytokines (IL-1α, IL-1β, G-CSF, GM-CSF, IL-6, and IL-772 
8) secreted from vaginal epithelial cells in response to different concentrations of 773 
Candidalysin. Statistics are applied relative to the vehicle control (n=3 biological 774 
repeats). Graphs are plotted as the mean + SEM. A and C-H: Statistical significance 775 
was calculated using one-way ANOVA and Dunnet’s post-test. *** p < 0.001, ** p < 776 
0.01, * p < 0.05. 777 
 778 
Figure 4. Candidalysin is required for neutrophil recruitment and mucosal 779 
damage in a murine model of vulvovaginal candidiasis. Groups of estrogen-treated 780 
C57BL/6 mice (n=4) were intravaginally challenged with WT (black bars), ece1Δ/Δ (dark 781 
gray bars), ece1Δ/Δ+ECE1Δ184-279 (white bars), and ece1Δ/Δ+ECE1 (light gray bars) 782 
strains of C. albicans and vaginal lavage fluid assessed longitudinally at d 3 and d 7 for 783 
(A, B) fungal burden, median; (C, D) PMNs, mean + SEM; (E, F) the damage biomarker 784 
LDH, mean + SEM. (G) Papanicolaou staining was performed on smears made from 785 
vaginal lavage fluid to assess PMN influx (yellow arrows) and hypha formation (green 786 
arrows) at d 3 and d 7 p.i. and are representative images. All inoculation groups were 787 
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performed in duplicate and data combined. A-F: Statistical significance was calculated 788 
using a one-way ANOVA and Tukey’s post-test. *** p < 0.001, ** p < 0.01, * p < 0.05. 789 
 790 
Figure 5. Candidalysin is required for pro-inflammatory cytokine expression in 791 
the murine vagina. Groups of estrogen-treated C57BL/6 mice (n=4) were intravaginally 792 
challenged with WT (black bars), ece1Δ/Δ (dark gray bars), ece1Δ/Δ+ECE1Δ184-279 793 
(white bars), and ece1Δ/Δ+ECE1 (light gray bars) strains of C. albicans, whole vaginal 794 
tissue excised at d 3 p.i., and extracted RNA processed for qPCR analysis. Genes 795 
chosen for qPCR included those previously identified as being induced by candidalysin 796 
or C. albicans during in vitro or in vivo challenge, including: (A) Il-6, (B) Cxcl1, (C) 797 
Cxcl2, (D) Il-1a, (E) Il-1b, (F) Gm-csf, (G) G-csf, (H) Camp, (I) Defb3, (J) S100A8, and 798 
(K) Saa3. All genes were internally compared to the Actb housekeeping gene and to 799 
mock-infected controls using the ΔΔCt method. Graphs are plotted as the mean 800 
normalized fold expression + SEM. Statistical significance was calculated using a one-801 
way ANOVA and Tukey’s post-test. ** p < 0.01, * p < 0.05. 802 
 803 
Figure 6. Candidalysin is required for release of hallmark proinflammatory 804 
cytokines and chemokines into the vaginal lavage fluid during murine vaginitis. 805 
Groups of estrogen-treated C57BL/6 mice (n=4) were intravaginally challenged with WT 806 
(black bars), ece1Δ/Δ (dark gray bars), ece1Δ/Δ+ECE1Δ184-279 (white bars), and 807 
ece1Δ/Δ+ECE1 (light gray bars) strains of C. albicans and vaginal lavage fluid assessed 808 
longitudinally by ELISA at d 3 and d 7 p.i. for inflammatory markers, including (A, B) IL-809 
1, (C, D) IL-1, (E, F) Cxcl2, (G, H) S100a8. All inoculation groups were performed in 810 
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duplicate and data combined. Graphs are plotted as the mean + SEM. Statistical 811 
significance was calculated using a one-way ANOVA and Tukey’s post-test. *** p < 812 
0.001, ** p < 0.01, * p < 0.05. 813 
 814 






